Upgrading on radical prostatectomy specimens of very low- and low-risk prostate cancer patients on active surveillance: A population-level analysis

Authors

  • Rashid K. Sayyid
  • Brandon Wilson
  • John Z. Benton
  • Atul Lodh
  • Eric F. Thomas
  • Hanan Goldberg
  • Rabii Madi
  • Martha K. Terris
  • Christopher J.D. Wallis
  • Zachary Klaassen

DOI:

https://doi.org/10.5489/cuaj.6868

Keywords:

Active Surveillance, Prostatic Neoplasms, Prostatectomy

Abstract

Introduction: A proportion of prostate cancer (PCa) patients initially managed with active surveillance (AS) are upgraded to a higher Gleason score (GS) at the time of radical prostatectomy (RP). Our objective was to determine predictors of upgrading on RP specimens using a national database.

Methods: The Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting database was used to identify AS patients diagnosed with very low- or low-risk PCa who underwent delayed RP between 2010 and 2015. The primary outcome was upgrading to GS 7 disease or worse. Logistic regression analyses were used to evaluate demographic and oncological predictors of upgrading on final specimen.

Results: A total of 3775 men underwent RP after a period of AS, 3541 (93.8%) of whom were cT2a; 792 (21.0%) patients were upgraded on RP specimen, with 85.4%, 10.6%, and 3.4% upgraded to GS 7(3+4), 7(4+3), and 8 diseases, respectively. On multivariable analysis, higher prostate-specific antigen (PSA) at diagnosis (5–10 vs. 0–2 ng/ml, odd ratio [OR] 2.59, p<0.001) and percent core involvement (80–100% vs. 0–20%, OR 2.52, p=0.003) were significant predictors of upgrading on final RP specimen, whereas higher socioeconomic status predicted lower odds of upgrading (highest vs. lowest quartile OR 0.75, p=0.013).

Conclusions: Higher baseline PSA and percent positive cores involvement are associated with significantly increased risk of upgrading on RP after AS, whereas higher socioeconomic status predicts lower odds of such events. These results may help identify patients at increased risk of adverse pathology on final specimen who may benefit from earlier definitive treatment.

Downloads

Download data is not yet available.

Published

2020-12-15

How to Cite

Sayyid, R. K., Wilson, B., Benton, J. Z., Lodh, A., Thomas, E. F., Goldberg, H., Madi, R., Terris, M. K., Wallis, C. J., & Klaassen, Z. (2020). Upgrading on radical prostatectomy specimens of very low- and low-risk prostate cancer patients on active surveillance: A population-level analysis. Canadian Urological Association Journal, 15(7), E335–9. https://doi.org/10.5489/cuaj.6868

Issue

Section

Original Research